Same Gland, Three Different Diseases
The prostate is a small gland that sits below the bladder and surrounds the urethra. By age 50, most men experience symptoms related to their prostate at some point. The challenge is that three very different conditions — prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer — can cause overlapping symptoms.
Distinguishing them matters because the workup and treatment differ dramatically. At Zimmer Medical Group, we evaluate prostate-related symptoms with a structured approach that avoids both under-investigation and over-testing.
How They Differ
| Feature | Prostatitis | BPH | Prostate Cancer | |---------|-------------|-----|-----------------| | Typical age | Any adult age | Usually > 50 | Usually > 50 | | Onset | Often acute or subacute | Gradual | Usually silent until advanced | | Pelvic pain | Common, often prominent | Uncommon | Uncommon (until advanced) | | Fever | Acute bacterial: yes | No | No | | Urinary symptoms | Often present | Predominant feature | Often absent in early disease | | PSA | May be elevated, sometimes dramatically | Often mildly elevated | May be elevated; can be normal | | DRE findings | Tender, boggy (acute) | Smooth, enlarged | Hard nodule (sometimes) |
Prostatitis
Prostatitis is inflammation of the prostate. Several distinct types exist:
Acute Bacterial Prostatitis
- Sudden onset
- Fever, chills, severe systemic symptoms
- Severe perineal/pelvic pain
- Painful urination, frequency, urgency
- Sometimes urinary retention
- Can progress to sepsis quickly
Treatment requires prompt antibiotics, often initially IV. This is the only form of prostatitis where bacteria are clearly the cause and antibiotic treatment is unambiguously effective.
Chronic Bacterial Prostatitis
- Recurrent UTIs caused by the same organism
- Pelvic discomfort
- Urinary symptoms
Treated with prolonged antibiotic courses (4–6 weeks), often with fluoroquinolones or TMP-SMX with good prostate penetration.
Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
- The most common form of prostatitis (>90 percent of cases)
- Pelvic, perineal, or genital pain lasting > 3 months
- Urinary symptoms variable
- Erectile or ejaculatory dysfunction sometimes present
- No identifiable bacterial infection
Treatment is challenging and usually multimodal:
- Alpha blockers (tamsulosin, alfuzosin) often help
- Pelvic floor physical therapy is effective for many patients
- Limited evidence for antibiotics in absence of bacteria
- Address chronic pain management approaches
- Stress management and cognitive behavioral therapy help selected patients
Asymptomatic Inflammatory Prostatitis
Discovered incidentally — no symptoms, no treatment usually needed.
BPH (Benign Prostatic Hyperplasia)
BPH is the gradual non-cancerous enlargement of the prostate that occurs in most men with age. Symptoms cluster as "lower urinary tract symptoms" (LUTS):
Storage Symptoms
- Urinary frequency
- Nocturia (waking at night to urinate)
- Urgency
- Urge incontinence
Voiding Symptoms
- Hesitancy (delayed start)
- Weak stream
- Intermittent stream
- Straining to urinate
- Dribbling at end of urination
Post-Voiding Symptoms
- Sense of incomplete emptying
- Continued dribbling
The International Prostate Symptom Score (IPSS) quantifies severity and tracks treatment response.
BPH Workup
- Symptom assessment
- Digital rectal exam
- Urinalysis (rule out infection, hematuria)
- PSA in appropriate candidates (after discussion)
- Post-void residual (PVR) urine measurement
- Sometimes ultrasound or urodynamic studies
BPH Treatment Options
Behavioral measures:
- Limit fluids in the evening
- Avoid bladder irritants (caffeine, alcohol)
- Treat constipation
- Pelvic floor strengthening
Medications:
- Alpha blockers (tamsulosin, alfuzosin, doxazosin) — relax prostate smooth muscle; rapid effect; common side effects include orthostatic hypotension and retrograde ejaculation
- 5-alpha reductase inhibitors (finasteride, dutasteride) — shrink the prostate over months; reduce PSA; small risk of sexual side effects
- Combination therapy (e.g., dutasteride + tamsulosin) for larger prostates
- PDE5 inhibitors (tadalafil 5 mg daily) — improve LUTS and erectile function simultaneously
- Beta-3 agonists (mirabegron) for predominantly storage symptoms
- Anticholinergics for storage symptoms (use cautiously in older adults)
Procedural options:
For patients failing or intolerant to medications:
- Transurethral resection of prostate (TURP) — traditional gold standard
- Laser procedures (HoLEP, GreenLight)
- UroLift
- Rezum (water vapor therapy)
- Prostatic artery embolization
- Aquablation
- Open or robotic simple prostatectomy for very large prostates
Prostate Cancer
The most common non-skin cancer in men. Most prostate cancers grow slowly; some are aggressive.
Risk Factors
- Age (rare under 40, common over 65)
- Family history (especially first-degree relative)
- African American ethnicity
- BRCA1/BRCA2 mutations
- Lynch syndrome
- Diet high in red meat, low in vegetables (modest association)
Symptoms
Early prostate cancer is usually silent. Symptoms suggesting more advanced disease:
- Bone pain
- Weight loss
- Fatigue
- Hematuria
- New significant urinary symptoms
- Erectile dysfunction (typically a late finding)
Most early prostate cancers are detected through PSA screening, not symptoms. See our PSA screening article for the screening discussion.
Diagnostic Workup
When prostate cancer is suspected:
- Confirmatory PSA, often with PSA velocity
- Digital rectal exam
- Multiparametric MRI of the prostate (increasingly first step)
- Targeted prostate biopsy (MRI-guided when possible)
- If diagnosed, additional staging based on risk
Treatment Approach
Treatment depends on stage, grade (Gleason score), patient age, and life expectancy:
- Active surveillance — for low-risk disease in selected patients
- Surgery (radical prostatectomy) — open, laparoscopic, or robotic
- Radiation therapy — external beam, brachytherapy, or combination
- Hormonal therapy (androgen deprivation) — for advanced or high-risk disease
- Chemotherapy — for metastatic disease
- Targeted therapies and immunotherapy — increasingly available for advanced disease
The decision is highly individualized and benefits from urology and sometimes radiation oncology consultation.
How These Conditions Interact
It's important to note:
- BPH does not cause or progress to prostate cancer — they are separate diseases
- However, both become more common with age, so many men have both
- Prostatitis can cause confusing PSA elevations
- Some symptoms (urinary issues) can result from any of the three
This is why a careful history, physical exam, and structured workup matter.
When to See Your Doctor
- New or worsening urinary symptoms
- Pelvic, perineal, or genital pain
- Pain or burning with urination
- Difficulty urinating or inability to urinate (urinary retention is an emergency)
- Blood in the urine or semen
- Fever with urinary symptoms
- Concerns about screening or test results
- Family history of prostate cancer plus age 40+
For all men with significant urinary symptoms, evaluation matters because the right diagnosis leads to the right treatment.
The American Urological Association and American Cancer Society provide additional patient resources on each condition.
Urinary symptoms or concerns about prostate health? Contact Zimmer Medical Group for an evaluation that distinguishes between these three conditions and the right next steps for whichever applies to you.
